Calidi Biotherapeutics (CLDI) Q2 2025 Earnings

14MayConfirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
-2.75
-2.05
-1.35
-0.65

Details

Expected EPS
-1.8
Actual EPS
-2.16
Surprise EPS
-0.36
Surprise Percent
+20%

Description

Calidi Biotherapeutics (CLDI) has reported earnings of -2.16 per share for Q2 2025.

0 Comments

Share your thoughts